MarketInOut Stock Screener Log In | Sign Up
 

Sanofi S.A.

OTC • Healthcare • Drug Manufacturers - General • Quote as of 07/20/2026 10:12
Sanofi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization103,483 mln
Float1,087 mln
Earnings Date04/23/2026

EPS

4.51
Solid

P / E

19.41
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.45
Borderline

Relative Strength

68 / 100
Outperforming

Debt / Equity

0.28
Very low leverage

Business Description

Sanofi is a global healthcare company based in Paris, France, focused on discovering, developing, and bringing to market treatments across a wide range of serious medical conditions, including cancer, rare diseases, neurological disorders, and inflammatory diseases. The company also produces a broad portfolio of vaccines protecting against illnesses such as polio, hepatitis, rabies, and respiratory infections. To strengthen its research capabilities, Sanofi has built an extensive network of partnerships with biotechnology and artificial intelligence companies, working together to advance new therapies in areas such as gene editing, protein degradation, and immune disease treatment. Founded in 1994 and formerly known as Sanofi-Aventis, the company operates on a global scale with a strong commitment to scientific innovation.

Key Fundamentals

EPS4.51
P/E19.41
ROE11.06
RPS44.24
ROIC7.30
ROA6.29
Interest Cover15.34
EBITDA, mln14,513
EV / EBITDA8.39
EV / EBIT15.39
Revenue, mln54,328
EV / Revenue2.24

Financial Strength

Altman Z-Score1.55
Piotroski F-Score 7 / 9
Beneish M-Score-2.45
Price to Intrinsic Value0.73
Price to Graham Number3.51
Shiller PE Ratio13.18

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.87% 80 / 100   
1 Month 3.23% 60 / 100   
2 Months 3.18% 58 / 100   
6 Months -11.95% 41 / 100   
1 Year -18.38% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us